Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Haldre Sulev"'
Autor:
Gross-Paju Katrin, Lüüs Siiri-Merike, Raukas Elve, Sachez-Ferrero Elena, Beetz Christian, Tamm Riin, Braschinsky Mark, Boillot Catherine, Canzian Federico, Metspalu Andres, Haldre Sulev
Publikováno v:
BMC Neurology, Vol 10, Iss 1, p 17 (2010)
Abstract Background Hereditary spastic paraplegia (HSP) is a clinically and genetically heterogeneous disorder that can be an autosomal-dominant, autosomal-recessive, or X-linked disease. The most common autosomal-dominant form of the disease derives
Externí odkaz:
https://doaj.org/article/de3428b524b14556bcb84c59b218538d
Publikováno v:
In Neurotoxicology January 2020 76:138-143
Publikováno v:
In Seizure: European Journal of Epilepsy May 2016 38:11-16
Autor:
Jędrzejczak, Joanna, Marusic, Petr, Haldre, Sulev, Majkowska-Zwolińska, Beata, Bojinova-Tchamova, Veneta, Mameniskiene, Ruta, Mindruta, Ioana, Ravnik, Igor M., Szupera, Zoltan, Sykora, Pavol, Verzbickis, Aleksandrs, Daniluk, Jerzy
Publikováno v:
In Seizure: European Journal of Epilepsy July 2013 22(6):452-456
Publikováno v:
In Research in Social and Administrative Pharmacy June 2022 18(6) Supplement
Autor:
Bar-Or, Amit, Wiendl, Heinz, Montalban, Xavier, Alvarez, Enrique, Davydovskaya, Maria, Delgado, Silvia R., Evdoshenko, Evgeniy P., Giedraitiene, Natasa, Gross-Paju, Katrin, Haldre, Sulev, Herrman, Craig E., Izquierdo, Guillermo, Karelis, Guntis, Leutmezer, Fritz, Mares, Miroslav, Meca-Lallana, Jose Eustasio, Mickeviciene, Dalia, Nicholas, Jacqueline, Robertson, Derrick S., Sazonov, Denis V., Sharlin, Kenneth, Sundaram, Bharathy, Totolyan, Natalia, Vachova, Marta, Valis, Martin, Bagger, Morten, Häring, Dieter A., Ludwig, Inga, Willi, Roman, Zalesak, Martin, Su, Wendy, Merschhemke, Martin, Fox, Edward J., Universitat Autònoma de Barcelona
Publikováno v:
Multiple sclerosis, London : Sage Publications Ltd., 2022, vol. 28, no. 6, p. 910-924
Scientia
Scientia
Ofatumumab; Multiple sclerosis; Pharmacokinetics Ofatumumab; Esclerosis múltiple; Farmacocinética Ofatumumab; Esclerosi múltiple; Farmacocinètica Background: Ofatumumab, the first fully human anti-CD20 monoclonal antibody, is approved in several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea82473f15eae98cbca7008483f7bdd
https://pubmed.ncbi.nlm.nih.gov/34605319
https://pubmed.ncbi.nlm.nih.gov/34605319
Publikováno v:
In Epilepsy & Behavior December 2021 125
Publikováno v:
In Epilepsy Research 2009 84(2):194-200
Publikováno v:
In Archives of Physical Medicine and Rehabilitation 2009 90(11):1887-1890
Autor:
Bar-Or, Amit, Wiendl, Heinz, Montalban, Xavier, Alvarez, Enrique, Davydovskaya, Maria, Delgado, Silvia R, Evdoshenko, Evgeniy P, Giedraitiene, Natasa, Gross-Paju, Katrin, Haldre, Sulev, Herrman, Craig E, Izquierdo, Guillermo, Karelis, Guntis, Leutmezer, Fritz, Mares, Miroslav, Meca-Lallana, Jose E, Mickeviciene, Dalia, Nicholas, Jacqueline, Robertson, Derrick S, Sazonov, Denis V, Sharlin, Kenneth, Sundaram, Bharathy, Totolyan, Natalia, Vachova, Marta, Valis, Martin, Bagger, Morten, Häring, Dieter A, Ludwig, Inga, Willi, Roman, Zalesak, Martin, Su, Wendy, Merschhemke, Martin, Fox, Edward J
Supplemental material, sj-docx-1-msj-10.1177_13524585211044479 for Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study by Amit Bar-Or, Heinz Wiendl, Xavier Montalban, E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7a476dbf9367c27866ee3f0be3801ee
